We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 501.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2023 to Jan 2025
TIDMMDC
RNS Number : 6902A
Mediclinic International plc
25 May 2023
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
South African income tax number: 9432434182
('Mediclinic', the 'Company', or the 'Group')
25 May 2023
NOTIFICATION: TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES & PERSONS CLOSELY ASSOCIATED WITH THEM
Vesting of awards under the Company's Short-Term Incentive ('STI') scheme and Long-Term Incentive Plan ('LTIP')
In connection with the recommended cash acquisition of Mediclinic by Manta Bidco Limited (a newly formed company owned by: (i) Remgro Limited and certain of its subsidiaries; and (ii) SAS Shipping Agencies Services S.à r.l., a wholly owned subsidiary of MSC Mediterranean Shipping Company SA) (the 'Acquisition'), this notification sets out the details of the vesting of awards over ordinary shares in Mediclinic granted under the Company's STI and LTIP to Directors and other persons discharging managerial responsibilities ('PDMRs') in the financial years ended on 31 March 2020, 31 March 2021, 31 March 2022 and 31 March 2023.
The awards vested on 24 May 2023 and will be settled in cash, based on the offer price to be paid by Manta Bidco Limited in connection with the Acquisition, being 501 pence per share.
The notifications that follow are made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.
Hot Features
Premium
1. Details of PDMR / person closely associated with them
a) Name Dr Carel Aron van der Merwe
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Group Chief Executive Officer - Mediclinic
International plc
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4.1 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 19 June 2019;
2. 14 December 2020;
3. 4 June 2021; and
4. 5 August 2022.
Vesting of deferred awards over ordinary
shares in Mediclinic granted at nil cost
under the Company's STI on:
5. 4 June 2021; and
6. 5 August 2022
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
1. GBPnil 45 185
----------
2. GBPnil 176 093
----------
3. GBPnil 118 727
----------
4. GBPnil 49 524
----------
5. GBPnil 122 614
----------
6. GBPnil 74 718
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
586 861
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Petrus Jurgens Myburgh
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Group Chief Financial Officer - Mediclinic
International plc
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4.1 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 19 June 2019;
2. 14 December 2020;
3. 4 June 2021; and
4. 5 August 2022.
Vesting of deferred awards over ordinary
shares in Mediclinic granted at nil cost
under the Company's STI on:
5. 4 June 2021; and
6. 5 August 2022
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
1. GBPnil 24 981
----------
2. GBPnil 97 549
----------
3. GBPnil 63 523
----------
4. GBPnil 30 900
----------
5. GBPnil 80 655
----------
6. GBPnil 47 488
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
345 096
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Gert Cornelis Hattingh
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Group Chief Governance Officer - Mediclinic
International plc
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
1. GBPnil 37 839
----------
2. GBPnil 24 331
----------
3. GBPnil 5 983
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
68 153
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Dr Dirk Cornelius le Roux
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Group Chief Information Officer - Mediclinic
International plc
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
1. GBPnil 29 654
----------
2. GBPnil 19 053
----------
3. GBPnil 4 677
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
53 384
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Dr Daniel Liedtke
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Chief Executive Officer: Hirslanden
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
1. GBPnil 70 352
----------
2. GBPnil 39 423
----------
3. GBPnil 10 849
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
120 624
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Magnus Oetiker
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Group Chief Strategy Officer - Mediclinic
International plc
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
1. GBPnil 56 587
----------
2. GBPnil 32 303
----------
3. GBPnil 10 822
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
99 712
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Koert Hendrik Stefanus Pretorius
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Group Chief Operating Officer - Mediclinic
International plc
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
1. GBPnil 39 509
----------
2. GBPnil 25 469
----------
3. GBPnil 6 261
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
71 239
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Dr René Toua
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Group Chief Clinical Officer - Mediclinic
International plc
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
1. GBPnil 30 301
----------
2. GBPnil 19 829
----------
3. GBPnil 4 915
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
55 045
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Dr Tyson Bruno Welzel
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Group Chief Innovation Officer - Mediclinic
International plc
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
1. GBPnil 24 080
----------
2. GBPnil 15 896
----------
3. GBPnil 8 460
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
48 436
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Hein van Eck
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Chief Executive Officer - Mediclinic Middle
East
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
4. 14 December 2020;
5. 4 June 2021; and
6. 5 August 2022.
----------------------- -------------------------------------------------
c) Price(s) and
volume(s) Price(s) Volume(s)
4. GBPnil 8 833
----------
5. GBPnil 5 011
----------
6. GBPnil 2 102
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
15 946
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
1. Details of PDMR / person closely associated with them
a) Name Greg van Wyk
----------------------- -------------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------
a) Position / status Chief Executive Officer: Mediclinic Southern
Africa
----------------------- -------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- -------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- -------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- -------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
----------------------- -------------------------------------------------
b) Nature of the Vesting of conditional awards over ordinary
transaction shares in Mediclinic granted at nil cost
under the Company's LTIP on:
1. 14 December 2020;
2. 4 June 2021; and
3. 5 August 2022.
----------------------- -------------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) 4. GBPnil 22 919
----------
5. GBPnil 14 800
----------
6. GBPnil 5 681
----------
----------------------- -------------------------------------------------
d) Aggregated information
Aggregated volume
43 400
Price
GBPnil
----------------------- -------------------------------------------------
e) Date of the 24 May 2023
transaction
----------------------- -------------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- -------------------------------------------------
CONTACT INFORMATION
Investor queries
James Arnold, Head of Investor Relations, Mediclinic International plc
+44 (0)20 3786 8181
ir@mediclinic.com
Media queries
FTI Consulting
Ben Atwell/Ciara Martin - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6(th) Floor, 65 Gresham Street, London, EC2V 7NQ , United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBDGDUSBDDGXU
(END) Dow Jones Newswires
May 25, 2023 09:00 ET (13:00 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
